Per Stirling Capital Management, Llc. Pfizer Inc Transaction History

Per Stirling Capital Management, Llc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $18,997 - $22,205	-592 Reduced 5.12%	10,961 $364 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $9,499 - $10,990	-263 Reduced 2.23%	11,553 $424 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $107,574 - $140,045	-2,731 Reduced 18.77%	11,816 $482 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $607,337 - $792,811	14,547 New	14,547 $745 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Per Stirling Capital Management, Llc., based on Form 13F filings with the SEC.

Stay updated on Per Stirling Capital Management, Llc. with notifications on news.